Clinical trial
Phase I Study About Effects of Caffeine, Methylphenidate, Modafinil and Placebo on Cognitive Performance of Chess Players.
NCT01834547 is registered in ClinicalTrials.gov with K. Lieb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study About Effects of Caffeine, Methylphenidate, Modafinil and Placebo on Cognitive Performance of Chess Players.
- Lead sponsor
- K. Lieb
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- April 30, 2013
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitively healthy subjects influenced by psychoactive drugs